CAM
ATRS

Costello Asset Management’s Antares Pharma, Inc. ATRS Stock Holding History

Costello Asset Management’s Portfolio ATRS Stock Details ATRS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-10,000
Closed -$41K – 264
2021
Q1 		$41K Hold
10,000
– – 0.03% 124
2020
Q4 		$40K Hold
10,000
– – 0.03% 120
2020
Q3 		$27K Hold
10,000
– – 0.02% 120
2020
Q2 		$28K Buy
+10,000
New +$27.9K 0.03% 113

Other funds holding ATRS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SIG
Sargent Investment Group Bethesda, Maryland $759M AUM 28.58% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
FWSM
First Wilshire Securities Management Pasadena, California $444M AUM 42.88% 1-Year Est. Return
Amundi
Amundi Paris, France $367B AUM 31.23% 1-Year Est. Return

Costello Asset Management's ATRS Position: Q2 2021 in Review

Costello Asset Management sold out of Antares Pharma, Inc. (ATRS) in Q2 2021, closing a stake of 10,000 shares — an estimated $41K sold.

Costello Asset Management first reported a position in ATRS in Q2 2020 and held it in 4 quarters. The position peaked at $41K in Q1 2021. 175 funds tracked by Wall St. Rank hold ATRS as of Q2 2021.

  • Costello Asset Management reported no remaining Antares Pharma, Inc. position as of Q2 2021 after selling out during the quarter.
  • Costello Asset Management sold 10,000 Antares Pharma, Inc. shares in Q2 2021, an estimated $41K.
  • Costello Asset Management first reported a position in Antares Pharma, Inc. in Q2 2020 and held it in 4 quarters.
  • Costello Asset Management's Antares Pharma, Inc. position peaked at $41K in Q1 2021.
  • 175 funds tracked by Wall St. Rank held Antares Pharma, Inc. as of Q2 2021.

Based on Costello Asset Management's 13F filing for Q2 2021, filed 5 Aug 2021.